XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 165,904,797 $ 564,124
Restricted cash 50,000
Deferred offering costs 121,712
Prepaid expenses and other current assets 1,160,257 78,057
Total current assets 167,115,054 763,893
Non-current assets:    
Property and equipment, net 760,548 458,591
Goodwill 29,367,213
Other assets 1,664,442
Total assets 198,907,257 1,222,484
Current liabilities:    
Accounts payable 1,912,553 715,653
Accrued expenses 1,569,348 2,634,790
Short-term debt 370,793
Right-of-use liability, current 34,079
Total current liabilities 3,886,773 3,350,443
Non-current liabilities:    
Right-of-use liability, long-term 394,721
Total liabilities 4,281,494 3,350,443
Commitments and Contingencies (Note 6)
Stockholders' Equity (Deficit)    
Preferred Stock, $0.001 par value, authorized 10,000,000 shares: Series 1 Convertible Preferred Stock, 8,028 and 0 shares authorized at September 30, 2020 and December 31, 2019, respectively, 8,027 and 0 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively. 8
Common Stock, $0.001 par value, authorized 100,000,000 shares: Common Stock, 10,521,840 and 2,627,533 common shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively. 10,522 2,628
Additional Paid in Capital 232,567,265 10,651,073
Accumulated Deficit (37,952,032) (12,781,660)
Total Stockholders' Equity (Deficit) 194,625,763 (2,127,959)
Total Liabilities and Stockholders' Equity (Deficit) $ 198,907,257 $ 1,222,484